SCHEMBL10288604

SCHEMBL10288604

CC(c1ccc2cc(F)ccc2c1)c1c(C(=O)O)sc(N2CCOCC2)c1C#N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 8/20 0.48
PIK3CD O00329 5/20 0.38
PIK3CB P42338 5/20 0.38
CYP3A4 P08684 3/20 0.38
GRIA2 P42262 1/20 0.38
GRIA4 P48058 1/20 0.38
PIK3R1 P27986 3/20 0.37
PIK3CG P48736 3/20 0.37
MTOR P42345 1/20 0.37
KCNQ2 O43526 1/20 0.36
CHRNA7 P36544 1/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KIT P10721 1/20 0.34
LRRK2 Q5S007 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625724 0.91 PIK3CA (0.49) PIK3CAPIK3CDPIK3CBCYP3A4GRIA2
SCHEMBL10308557 0.86 HPGD (0.36) PIK3CAPIK3CDPIK3CBPIK3R1PIK3CG
SCHEMBL10288591 0.84 PIK3CA (0.36) PIK3CAPIK3CDPIK3CBCYP3A4PIK3R1
SCHEMBL10288545 0.84 PIK3CA (0.55) PIK3CACYP3A4GRIA2GRIA4PIK3R1
SCHEMBL10298520 0.84 CYP3A4 (0.36) PIK3CAPIK3CDPIK3CBCYP3A4PIK3CG
SCHEMBL10288561 0.82 PIK3CA (0.50) PIK3CAPIK3CDPIK3CBCYP3A4GRIA2
SCHEMBL10006005 0.80 PIK3CA (0.50) PIK3CACYP3A4GRIA2GRIA4PIK3R1
SCHEMBL10288308 0.80 PIK3CA (0.49) PIK3CACYP3A4GRIA2GRIA4PIK3R1
SCHEMBL622922 0.79 PIK3CA (0.47) PIK3CACYP3A4GRIA2GRIA4PIK3R1
SCHEMBL623940 0.79 ALDH1A1 (0.43) PIK3CAMAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885PIK3CD 18/4885PIK3CB 19/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885PIK3CD 18/4885PIK3CB 19/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885PIK3CD 19/4885PIK3CB 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.